seroepidemiolog
studi
detect
antibodi
hatman
coronavirus
neonat
calf
diarrhea
coronaviru
ncdcv
carri
use
sera
collect
hospit
patient
healthi
person
routin
laboratori
test
northern
itali
patient
test
children
adult
differ
patholog
diseas
antibodi
detect
perform
use
indirect
immunoperoxidas
stain
techniqu
gor
virus
case
ncdcv
antibodi
detect
obtain
even
hemagglutin
inhibit
test
plaqu
reduct
neutral
assay
result
obtain
show
signific
differ
preval
antibodi
betteen
children
adult
group
furthermor
differ
tirer
observ
within
two
group
patient
affect
hematolog
diseas
leukemia
patient
w
h
diseas
final
data
seem
confirm
previou
studi
report
high
preval
antibodi
coronaviru
less
detect
seroposit
coronaviru
h
u
n
coronavirus
well
known
etiolog
agent
respiratori
infect
gener
affect
upper
respiratori
tract
respons
c
n
cold
winterspr
season
isol
virus
particularli
difficult
consequ
epidemiolog
reliabl
data
diffus
base
upon
serolog
studi
p
e
r
f
r
e
use
refer
strain
cell
cultur
adapt
coronavirus
date
virus
includ
coronaviru
group
properti
presenc
one
molecu
e
infecti
ssrna
mw
rang
dalton
polyadenyl
terminu
correspond
author
ii
morpholog
show
pleomorph
envelop
particl
diamet
rang
nm
surfac
project
spike
protrud
nm
envelop
iii
c
n
physicochemicai
properti
band
gcm
sucros
gradient
disrupt
bv
ether
chloroform
deterg
remov
surfac
project
bromelain
trypsin
consequ
virus
could
includ
coronaviru
group
independ
antigen
crossreact
particu
arli
characterist
morpholog
spike
reveal
electron
microscopi
h
u
n
coronaviru
prototyp
coronavirus
affect
human
particular
related
date
vol
antibodi
coronavim
ncdcv
port
two
virus
f
u
r
h
e
r
r
e
vitro
show
easi
growth
h
u
n
lung
fibroblast
cell
cultur
evid
cytopathogen
effect
hand
grow
cell
cultur
vero
cell
h
u
n
fibroblast
cell
cultur
adapt
viru
strain
cultur
suckl
mous
brain
despit
morpholog
antigen
differ
virus
respons
human
c
n
cold
easili
distinguish
p
season
appear
previou
report
show
high
preval
antibodi
h
u
n
coronaviru
sera
collect
f
r
patient
northern
itali
result
obtain
use
complex
test
immuneadher
hemagglutin
iaha
case
specif
antibodi
detect
highli
sensit
reliabl
test
complementfix
hemagglutinationinhibit
antibodi
detect
anoth
interest
test
util
serodiagnosi
infect
base
upon
microneutr
method
despit
high
degre
specif
sensit
perform
econom
expens
f
u
r
h
e
r
r
e
presenc
non
specif
inhibitor
ncdcv
coronaviru
present
l
n
sera
fetal
calf
serum
fg
remov
phospholipas
c
plc
treatment
p
r
p
e
us
develop
new
sensit
specif
hemagglutin
inhibit
test
new
plaqu
reduct
assay
use
new
test
foc
indirect
u
n
p
e
r
x
e
stain
techniqu
p
carri
seroepiderniolog
studi
order
verifi
previous
report
data
addit
strict
antigen
related
ncdcv
suggest
investig
preval
h
u
n
u
n
e
respons
bovin
viru
coronaviru
obtain
american
type
cultur
collect
atcc
rockvil
md
usa
adapt
grow
h
u
n
e
b
r
lung
fibroblast
cell
helf
ncdcv
coronavirus
cell
cultur
adapt
strain
origin
obtain
f
r
suckl
mous
brain
adapt
viru
suppli
dr
hs
kay
cdc
respiratori
virolog
unit
atlanta
ga
usa
dr
ca
mebu
dept
veterinari
scienc
univers
nebraska
lincoln
neb
adapt
growth
h
e
l
f
previous
report
three
h
u
n
r
e
twenti
nine
sera
collect
hospit
patient
healthi
person
routin
laboratori
test
univers
hospit
pavia
itali
sera
f
r
six
age
group
studi
specif
antibodi
ncdcv
coronavirus
n
u
b
e
r
sera
also
collect
f
r
leukem
infant
children
h
e
l
f
cell
cultur
steril
micropl
tissu
cultur
monolay
confluent
cell
well
infect
ml
suspens
contain
infecti
viru
particl
incub
rain
well
ad
ml
e
u
contain
fetal
calf
serum
infect
cultur
incub
hour
wash
time
pb
du
becco
b
fix
absolut
ethanol
fix
p
r
e
p
r
n
immedi
use
hp
store
use
p
specif
h
u
n
antibodi
detect
p
e
r
f
r
e
previous
describ
virus
except
colour
develop
system
use
antibodi
titer
ncdcv
detect
hi
follow
report
procedur
suggest
r
e
e
n
sera
order
avoid
nonspecif
inhibitor
ncdcv
hemagglutin
except
inactiv
phospholipas
c
plc
heat
r
e
e
n
rain
use
substitut
phenanthrolin
treatment
pra
ncdcv
antibodi
detect
p
e
r
f
r
e
previous
describ
briefli
titer
viru
suspens
known
contain
infecti
unit
viru
mix
equal
volum
serial
twofold
dilut
plc
treat
sera
dilut
serum
free
e
u
addit
glutamin
penicillin
streptomycin
gentamycin
mixtur
incub
rain
inocul
well
micropl
cell
cultur
helf
rotwel
adsorpt
rain
plaqu
e
u
e
u
fetal
calf
e
r
u
final
concentr
ncdcv
respect
ad
h
cell
fix
absolut
ethanol
stain
indirect
u
n
p
e
r
x
e
stain
techniqu
describ
use
mous
h
p
e
r
u
n
e
sera
figur
antibodi
coronaviru
present
high
percentag
sera
studi
preval
specif
antibodi
titer
increas
increas
age
antibodi
titer
leukem
patient
seem
consist
lower
patient
figur
result
obtain
particularli
differ
observ
previou
report
except
fact
greater
sensit
iip
techniqu
use
antibodi
titer
greater
furthermor
iip
test
easi
read
shown
figur
simpl
perform
avoid
problem
ie
fals
result
andor
difficulti
interpret
data
frequent
occur
use
convent
tediou
method
like
complement
fixat
immun
adher
hemagglutin
final
iip
techniqu
antibodi
detect
advantag
allow
prolong
storag
infect
fix
substrat
inexpens
antibodi
coronaviru
frequent
studi
popul
absenc
specif
u
n
e
respons
except
find
cours
survey
detect
specif
antibodi
use
hemaglutin
inhibit
test
h
gave
result
particularli
differ
previous
rep
r
e
sera
collect
f
r
patient
geograph
area
thu
confirm
high
preval
antibodi
respons
coronaviru
parallel
antibodi
detect
investig
u
n
e
respons
ncdcv
bovin
coronaviru
antigen
strictli
relat
antibodi
titer
gener
twofourfold
dilut
higher
titer
ncdcv
never
observ
sera
posit
neg
ncdcv
viceversa
pra
test
show
greater
sensit
h
titer
obtain
gener
fourfourfold
dilut
higher
u
n
e
respons
homolog
heterolog
ncdcv
viru
alway
proport
observ
use
h
test
figur
even
case
ncdcv
coronavirus
sera
f
r
leukem
patient
show
specif
antibodi
titer
lower
titer
observ
non
leukem
patient
group
age
case
l
p
result
obtain
pra
ncdcv
easili
readabl
interpret
shown
figur
coronavirus
e
b
e
r
group
viru
character
high
incid
n
l
n
speci
includ
man
h
u
n
coronavirus
gener
involv
c
n
cold
u
p
p
e
r
respiratori
tract
diseas
p
r
n
studi
h
u
n
coronavirus
present
w
r
k
search
antibodi
titer
coronaviru
use
sensit
test
furthermor
assay
sera
order
detect
antibodi
respons
ncdcv
coronaviru
known
crossreact
strongli
hum
n
data
obtain
r
e
sensit
reliabl
method
p
p
e
r
consist
confirm
previou
report
show
high
preval
coronaviru
northern
itali
agreement
result
obtain
countri
report
use
test
sensit
particularli
tediou
expens
hemagglutin
inhibit
ncdcv
p
e
r
f
r
e
destroy
non
specif
inhibitor
simpl
reliabl
test
sensit
specif
p
pra
ncdcv
describ
discuss
final
detect
u
n
e
respons
ncdcv
bovin
coronaviru
antigen
relat
crossreact
due
interest
confirm
antigen
relationship
exclud
h
u
n
sera
posit
react
ncdcv
latter
data
agreement
previous
report
result
render
question
report
refer
presenc
specif
h
u
n
antibodi
ncdcv
fact
detect
u
n
e
reactiv
h
u
n
sera
ncdcv
howev
u
alway
p
e
r
f
r
e
destroy
specif
serum
inhibitor
definit
confirm
depend
strict
antigen
related
ncdcv
consequ
h
u
n
immun
ncdcv
